These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 7693298)

  • 21. Early effects of intrastriatal injections of quinolinic acid on microtubule-associated protein-2 and neuropeptides in rat basal ganglia.
    Bordelon YM; Chesselet MF
    Neuroscience; 1999; 93(3):843-53. PubMed ID: 10473250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of subliminally primed responses is mediated by the caudate and thalamus: evidence from functional MRI and Huntington's disease.
    Aron AR; Schlaghecken F; Fletcher PC; Bullmore ET; Eimer M; Barker R; Sahakian BJ; Robbins TW
    Brain; 2003 Mar; 126(Pt 3):713-23. PubMed ID: 12566291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deep brain stimulation for Huntington's disease: long-term results of a prospective open-label study.
    Gonzalez V; Cif L; Biolsi B; Garcia-Ptacek S; Seychelles A; Sanrey E; Descours I; Coubes C; de Moura AM; Corlobe A; James S; Roujeau T; Coubes P
    J Neurosurg; 2014 Jul; 121(1):114-22. PubMed ID: 24702329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional distribution of methionine-enkephalin and substance P-like immunoreactivity in normal human brain and in Huntington's disease.
    Emson PC; Arregui A; Clement-Jones V; Sandberg BE; Rossor M
    Brain Res; 1980 Oct; 199(1):147-60. PubMed ID: 6157454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain.
    Perry TL; Hansen S; Kloster M
    N Engl J Med; 1973 Feb; 288(7):337-42. PubMed ID: 4345566
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea.
    Waters CM; Peck R; Rossor M; Reynolds GP; Hunt SP
    Neuroscience; 1988 May; 25(2):419-38. PubMed ID: 2456487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased glutamic acid and increased 5-hydroxytryptamine in Huntington's disease brain.
    Reynolds GP; Pearson SJ
    Neurosci Lett; 1987 Jul; 78(2):233-8. PubMed ID: 2442679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discriminating chorea-acanthocytosis from Huntington's disease with single-case voxel-based morphometry analysis.
    Suzuki F; Sato N; Ota M; Sugiyama A; Shigemoto Y; Morimoto E; Kimura Y; Wakasugi N; Takahashi Y; Futamura A; Kawamura M; Ono K; Nakamura M; Sano A; Watanabe M; Matsuda H; Abe O
    J Neurol Sci; 2020 Jan; 408():116545. PubMed ID: 31704285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cortical lesion of Huntington's disease: further neurochemical characterization, and reproduction of some of the histological and neurochemical features by N-methyl-D-aspartate lesions of rat cortex.
    Storey E; Kowall NW; Finn SF; Mazurek MF; Beal MF
    Ann Neurol; 1992 Oct; 32(4):526-34. PubMed ID: 1280937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of pallidum in genesis of some choreic movements.
    SPIEGEL EA; WYCIS HT
    Neurology; 1953 Apr; 3(4):261-6. PubMed ID: 13054853
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on neurotransmitter markers of the basal ganglia in Pick's disease, with special reference to dopamine reduction.
    Kanazawa I; Kwak S; Sasaki H; Muramoto O; Mizutani T; Hori A; Nukina N
    J Neurol Sci; 1988 Jan; 83(1):63-74. PubMed ID: 2450180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic and electrophysiological changes in the basal ganglia of transgenic Huntington's disease rats.
    Vlamings R; Benazzouz A; Chetrit J; Janssen ML; Kozan R; Visser-Vandewalle V; Steinbusch HW; von Hörsten S; Temel Y
    Neurobiol Dis; 2012 Dec; 48(3):488-94. PubMed ID: 22813864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.
    Lastres-Becker I; Hansen HH; Berrendero F; De Miguel R; Pérez-Rosado A; Manzanares J; Ramos JA; Fernández-Ruiz J
    Synapse; 2002 Apr; 44(1):23-35. PubMed ID: 11842443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevation of Met-enkephalin-like immunoreactivity in the rat striatum and globus pallidus following the focal injection of excitotoxins.
    Ruzicka BB; Jhamandas K
    Brain Res; 1990 Dec; 536(1-2):227-39. PubMed ID: 2150770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution and binding parameters of GABAA receptors in the thalamic nuclei of Macaca mulatta and changes caused by lesioning in the globus pallidus and reticular thalamic nucleus.
    Ambardekar AV; Surin A; Parts K; Ilinsky IA; Kultas-Ilinsky K
    Neuroscience; 2003; 118(4):1033-43. PubMed ID: 12732248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early GABAergic transmission defects in the external globus pallidus and rest/activity rhythm alteration in a mouse model of Huntington's disease.
    Du Z; Chazalon M; Bestaven E; Leste-Lasserre T; Baufreton J; Cazalets JR; Cho YH; Garret M
    Neuroscience; 2016 Aug; 329():363-79. PubMed ID: 27217211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced striatopallidal gamma-aminobutyric acid (GABA)
    Perez-Rosello T; Gelman S; Tombaugh G; Cachope R; Beaumont V; Surmeier DJ
    Mov Disord; 2019 May; 34(5):684-696. PubMed ID: 30726572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms underlying the enhancement of γ-aminobutyric acid responses in the external globus pallidus of R6/2 Huntington's disease model mice.
    Barry J; Sarafian TA; Watson JB; Cepeda C; Levine MS
    J Neurosci Res; 2020 Nov; 98(11):2349-2356. PubMed ID: 32856336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The globus pallidus as a target for neuropeptides and endocannabinoids participating in central activities.
    Chen XY; Xue Y; Chen H; Chen L
    Peptides; 2020 Feb; 124():170210. PubMed ID: 31778724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.